Children's Hospital of Philadelphia
34th Street and Civic Center Boulevard
367 articles with Children's Hospital of Philadelphia
ADHD Medications Associated with Reduced Risk of Suicidality in Children with Significant Behavioral Symptoms
In large observational study, CHOP researchers find ADHD drugs are associated with less suicidal behavior and thoughts in preadolescent children with substantial externalizing behaviors like hyperactivity and oppositional defiance
Children's Hospital of Philadelphia Appoints Susan L. Furth, MD, PhD as New Chief Scientific Officer
Following an extensive national search, Children's Hospital of Philadelphia has appointed Susan L. Furth, MD, PhD as Chief Scientific Officer.
Children's Hospital of Philadelphia Announces New Collaboration with University of Pennsylvania's Netter Center and Uplift Center for Grieving Children to Offer Innovative Grief and Trauma Programs for West & Southwest Philadelphia Students
Children's Hospital of Philadelphia announces a collaboration to help children cope with grief and violence, as part of the Healthier Together Initiative.
Children's Hospital of Philadelphia Establishes the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment
The Wood Family, Founding Family of Wawa, Funds Momentous Gift of $25 Million to Support New Era of Fetal Medicine at CHOP, Advance Promising Research, and Recruit World-Class Talent
CHOP-led study found depressive symptoms were uniquely associated with pandemic-related income loss and financial strain in two different countries, independent of anxiety
--CHOP team treated patient with the condition, known as PU.MA, thanks to a bone marrow donation from the patient's older brother--
- Breaking Through with Madeline Bell's Pioneered at CHOP series highlights stories about some of CHOP's amazing breakthroughs, told by the people who made them -
Study co-led by CHOP is the first to look at use of drugs like guanfacine in a large group of preschoolers with ADHD
Children's Hospital of Philadelphia Appoints Sophia G. Holder as New Executive Vice President and Chief Financial Officer
Children's Hospital of Philadelphia has appointed Sophia G. Holder as Executive Vice President and Chief Financial Officer.
Children's Hospital of Philadelphia announced the opening of a new, 37,000-square-foot Specialty Care Center in Abington, PA.
Award was presented to the St. Baldrick's Foundation-Stand Up 2 Cancer Pediatric Cancer Dream Team, co-led by CHOP, at the annual AACR conference
Dr. Tyra Bryant-Stephens Appointed Inaugural Leader of Children's Hospital of Philadelphia's Center for Health Equity
Children's Hospital of Philadelphia announced that Tyra Bryant-Stephens, M.D. has been appointed Senior Director of its Center for Health Equity.
Children's Hospital of Philadelphia Announces Opening of New Healthy Weight Food Pharmacy at its Nicholas and Athena Karabots Pediatric Care Center
With The GIANT Company's Support, CHOP's Second-generation Food Pharmacy Will Serve Patient Families at its West Philadelphia Primary Care Center
Combining computational mining of big data with experimental testing in the lab, researchers at Children's Hospital of Philadelphia have identified RNA editing events that influence gene expression and, in turn, the phenotypic manifestation of that expression.
CHOP/Penn study shows T cell activation in children with MIS-C more similar to adults with severe COVID-19
Findings may help doctors and parents know when a rash warrants further examination for the inflammatory syndrome
Follow up to landmark 2011 study shows children who had prenatal repair also have better self-care skills and are more independent up to 10 years later
Children's Hospital of Philadelphia Appoints Donald Moore as Senior Vice President of Real Estate, Facilities and Operations
Children's Hospital of Philadelphia has appointed Donald E. Moore as its Senior Vice President of Real Estate, Facilities and Operations.
--New preclinical study shows vector results in significantly more hemoglobin production than vectors currently used in gene therapy for sickle cell disease and beta-thalassemia--
FARE, the world's leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, has awarded two competitive grants to partner institutions that will bolster FARE's 2020 expansion of the FARE Clinical Network, powering advances in food allergy research.